AN2 Therapeutics, Inc., (ANTX) News

AN2 Therapeutics, Inc., (ANTX): $19.38

7.61 (+64.66%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ANTX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 401

in industry

Filter ANTX News Items

ANTX News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4325 seconds.